News Pfizer's breast cancer drug step closer to EU approval Ibrance is already Pfizer's top oncology product.
News Novo's next-gen diabetes drug could be best at cutting heart... Novo boosted by results from next-gen GLP-1.
News NHS to fund Pfizer's Bosulif and Lilly's Alimta NICE is reviewing drugs from old Cancer Drugs Fund.
News Bad news for Sanofi as biosimilar replaces Lantus Pharmacy benefit firm axes Lantus, decision due on key combination therapy.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.